UNICA IRIS Institutional Research Information System

BARCELLONA, DORIS
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 123.871
NA - Nord America 8.330
AS - Asia 3.950
SA - Sud America 762
Continente sconosciuto - Info sul continente non disponibili 541
AF - Africa 180
OC - Oceania 62
Totale 137.696
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 121.720
US - Stati Uniti d'America 8.108
SG - Singapore 1.449
CN - Cina 1.097
BR - Brasile 576
SE - Svezia 464
VN - Vietnam 418
GB - Regno Unito 325
DE - Germania 305
UA - Ucraina 259
FI - Finlandia 194
HK - Hong Kong 190
FR - Francia 163
BD - Bangladesh 143
IN - India 128
CA - Canada 118
NL - Olanda 90
KR - Corea 64
AR - Argentina 61
MX - Messico 58
JP - Giappone 55
IQ - Iraq 52
TR - Turchia 52
AU - Australia 50
ZA - Sudafrica 49
ES - Italia 44
AT - Austria 43
IE - Irlanda 43
PL - Polonia 40
PK - Pakistan 38
IR - Iran 36
EG - Egitto 33
ID - Indonesia 33
CO - Colombia 32
MA - Marocco 31
RU - Federazione Russa 29
EC - Ecuador 26
MY - Malesia 21
UZ - Uzbekistan 21
BE - Belgio 20
DK - Danimarca 20
PH - Filippine 19
CH - Svizzera 18
SA - Arabia Saudita 18
TW - Taiwan 16
KE - Kenya 15
PY - Paraguay 15
CL - Cile 13
JM - Giamaica 13
JO - Giordania 13
PE - Perù 13
TN - Tunisia 13
ET - Etiopia 12
LT - Lituania 12
CZ - Repubblica Ceca 11
NP - Nepal 11
NZ - Nuova Zelanda 11
VE - Venezuela 11
BG - Bulgaria 10
AE - Emirati Arabi Uniti 9
IL - Israele 9
HU - Ungheria 8
SD - Sudan 8
DZ - Algeria 7
RO - Romania 7
TH - Thailandia 7
CR - Costa Rica 6
PT - Portogallo 6
UY - Uruguay 6
BH - Bahrain 5
CY - Cipro 5
KZ - Kazakistan 5
NO - Norvegia 5
PR - Porto Rico 5
AZ - Azerbaigian 4
BA - Bosnia-Erzegovina 4
BY - Bielorussia 4
GE - Georgia 4
GY - Guiana 4
HN - Honduras 4
KG - Kirghizistan 4
LB - Libano 4
LV - Lettonia 4
MU - Mauritius 4
OM - Oman 4
PA - Panama 4
BO - Bolivia 3
DO - Repubblica Dominicana 3
EU - Europa 3
KW - Kuwait 3
LK - Sri Lanka 3
LU - Lussemburgo 3
MT - Malta 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
SY - Repubblica araba siriana 3
AL - Albania 2
CI - Costa d'Avorio 2
DM - Dominica 2
EE - Estonia 2
Totale 137.126
Salva come PNG Salva come JPEG
Città #
Cagliari 115.591
Uta 5.357
Fairfield 765
Ashburn 760
Singapore 679
Woodbridge 526
Dallas 518
San Jose 416
Houston 405
Boardman 313
Seattle 310
Nyköping 291
Chandler 290
Wilmington 287
Council Bluffs 282
Cambridge 261
Ann Arbor 246
Beijing 235
Los Angeles 176
Hong Kong 165
Santa Clara 139
Helsinki 137
Jacksonville 134
New York 122
Ho Chi Minh City 121
The Dalles 120
Shanghai 103
Lauterbourg 95
Dearborn 93
Boston 87
Hanoi 79
Rome 78
Buffalo 64
Milan 64
Dong Ket 58
San Diego 57
São Paulo 56
Nanjing 52
Munich 51
Chicago 48
Hefei 48
Seoul 47
Redwood City 42
Frankfurt am Main 39
Nuremberg 38
Redondo Beach 38
Guangzhou 37
Toronto 35
Tokyo 33
Columbus 32
Dublin 31
London 29
Warsaw 29
Vienna 28
Brooklyn 25
Johannesburg 25
Phoenix 25
Shenyang 25
Atlanta 24
Orem 23
Stockholm 23
Brandenburg 22
Denver 22
Amsterdam 21
San Francisco 21
Chennai 20
Mexico City 20
Tashkent 20
Tianjin 20
Sydney 19
Baghdad 18
Hebei 18
Montreal 18
Rio de Janeiro 18
Selargius 18
Ankara 17
Bogotá 17
Brussels 17
Haiphong 17
Turku 17
Changsha 16
College Station 16
Lahore 16
Manchester 16
Nanchang 16
Redmond 15
Central 14
Jiaxing 14
Nairobi 14
Naples 14
Salt Lake City 14
Mountain View 13
Mumbai 13
Amman 12
Istanbul 12
Orange 12
Sassari 12
Baoding 11
Biên Hòa 11
Cape Town 11
Totale 130.939
Salva come PNG Salva come JPEG
Nome #
Abnormal lipid accumulation and cluster formation of naive peripheral blood mononuclear cells: a useful tool for early detection of central nervous system damage in elderly 2.887
Heterogeneity of Antiphospholipid Syndrome (APS) as Characterized by Brain Perfusion Techniques. Towards New Ways of Syndrome Characterization 2.817
The venous thromboembolic risk and the clot wave analysis: a useful relationship? 2.776
Prophylaxis of peripartum haemorrhage using recombinant factor VIIa (rfVIIa) in pregnant women with congenital factor VII deficiency: A case report and literature review 2.761
Myocardial infarction and Antiphospholipid Syndrome: A first study on finger PPG waveforms effects 2.580
Dabigatran overdose: a case report of acute hepatitis. Extracorporeal treatment. 2.576
Olanzapine-associated portal and superior mesenteric vein thrombosis 2.524
Are prothrombin time and clot waveform analysis useful in detecting a bleeding risk in liver cirrhosis? 2.444
Telemedicine can improve the quality of oral anticoagulation using portable devices and self-testing at home 2.314
Clot wave analysis and thromboembolic score in liver cirrhosis: two opposing phenomena 2.305
Empathy and the Educational Approach to Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulants 2.185
Underuse of anticoagulant therapy in hospitalized older patients: comment on the article of Wojszel et al 2.170
Management of Patients Taking Oral Anticoagulants Who Need Urgent Surgery for Hip Fracture 2.158
Multiple specialized stem cell niches characterize hematopoiesis in the human fetal liver 2.085
Pulmonary Thrombosis: A Clinical Pathological Entity Distinct from Pulmonary Embolism? 2.082
Clot Waveform Analysis: From Hypercoagulability to Hypocoagulability - A Review 2.022
A Sardinian Family with Factor XI Deficiency 2.000
Ultrastructural findings of lung injury due to Vaccine-induced Immune Thrombotic Thrombocytopenia (VITT) following COVID-19 vaccination: a scanning electron microscopic study 1.973
Vaccine-induced severe thrombotic thrombocytopenia following COVID-19 vaccination: A report of an autoptic case and review of the literature 1.910
A “Catastrophic” Heparin-Induced Thrombocytopenia 1.891
The hemostatic system. 1st Part 1.819
Points of Care Testing International Normalized Ratio: Are They Useful for Monitoring Vitamin K Antagonists in a Thrombosis Center? 1.811
Molecular pathways triggered by COVID-19 in different organs: ACE2 receptor-expressing cells under attack? A review 1.759
Point-of-care testing INR: an overview 1.685
Has time come for the use of direct oral anticoagulants in the extended prophylaxis of venous thromboembolism in acutely ill medical patients? No 1.664
Pulmonary thrombosis in 2019-nCoV pneumonia? 1.658
Risk of reoperation in bioprosthetic valve patients with indication for longterm anticoagulation. Results from the observational retrospective multicentre PLECTRUM study 1.651
Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome 1.628
Patients' adherence to oral anticoagulants therapy: Comparison between vitamin K antagonists and direct oral anticoagulants 1.608
Mechanical prosthetic heart valves: Quality of anticoagulation and thromboembolic risk. The observational multicenter PLECTRUM study 1.585
Direct oral anticoagulants: what can we learn? 1.572
Comparison of prothrombin time INR and clot waveform analysis performed with 129-mmol/L and 105-mmol/L citrate tubes 1.564
Fatal Cytopenia Induced by Low-Dose Methotrexate in Elderly With Rheumatoid Arthritis. Identification of Risk Factors 1.516
The criteria of the Italian Federation of Thrombosis Centres on DOACs: a ‘‘real world’’ application in nonvalvular atrial fibrillation patients already on Vitamin K Antagonist 1.490
Allele 4G of gene PAI-I associated with prothrombin mutation G20210A increases the risk for venous thrombosis 1.464
Thrombosis centres and AVKs monitoring in COVID-19 pandemic 1.450
Ultrasound-guided fine-needle aspiration biopsy of thyroid nodules in patients on oral anticoagulants 1.393
Fondaparinux: Should It Be Studied in Patients with COVID-19 Disease? 1.369
Direct inhibitors of thrombin and factor Xa: the importance of laboratory skills 1.356
A guide to oral anticoagulation 1.333
Findings from a multicentre, observational study on reproductive outcomes in women with unexplained recurrent pregnancy loss: the OTTILIA registry 1.317
The Repeatable Battery for the Assessment of Neuropsychological Status as a screening strategy for HIV-Associated Neurocognitive Disorders 1.310
Portable coagulometer for vitamin K-antagonist monitoring: the patients’ point of view 1.308
Hyperhomocysteinemia: could the post-methionine oral loading test sometimes be avoided? 1.307
The Italian START-Register on anticoagulation with focus on atrial fibrillation 1.270
Antiphospholipid syndrome patients: The performance of Coagucheck XS in the monitoring of Vitamin K-Antagonists 1.259
Heparins and 2019-nCoV infection: a narrative review 1.249
A ‘‘two-step’’ educational approach for patients taking oral anticoagulants does not improve therapy control 1.233
Thyroid disorders and hypocoagulability 1.188
The predictive ability of bleeding risk stratification models in very old patients on vitaminK antagonist treatment for venous thromboembolism: results of the prospective collaborative EPICA study 1.184
Clinical course of high-risk patients diagnosed with antiphospholipid syndrome 1.154
High frequency of inadequate test requests for antiphospholipid antibodies in daily clinical practice 1.138
Vitamin K antagonists (coumarins), drugs used in the prevention and treatment of cardioembolism, deep vein thrombosis, and pulmonary embolism 1.130
Liver changes in Wilson’s disease: The full spectrum. A report of 127 biopsies from 43 patients 1.112
Fetal programming of atherosclerosis: may the barker hypothesis explain the susceptibility of a subset of patients to develop stroke or cardiac infarct? 1.095
Anticoagulation resumption after intracranial hemorrhage in patients treated with VKA and DOACs 1.091
Association of Antiplatelet and Anticoagulant Treatment in Patients with Mechanical Prosthetic Heart Valves. Data from the Observational Multicentre PLECTRUM Study 1.083
Rheumatoid arthritis and thrombosis 1.080
A routine silica-based activated partial thromboplastin time (Hemosil aPTT-SP (TM)) mostly excludes the presence of lupus anticoagulant 1.079
Prevalence and significance of anti-prothrombin (aPT) antibodies in patients with Lupus Anticoagulant (LA) 1.074
Fetal programming of COVID-19: May the barker hypothesis explain the susceptibility of a subset of young adults to develop severe disease? 1.018
Infectious agents including COVID-19 and the involvement of blood coagulation and fibrinolysis. A narrative review 1.014
Point-of-care (POCT) prothrombin time monitors: is a periodical control of their performance useful? 1.013
Clot characterization by multidisciplinary approach: biochemical and imaging parameters in a hypocoagulative setting. A pilot study 1.003
Management of DOAC in patients undergoing planned surgery or invasive procedure: FCSA position paper 987
Position paper on the safety/efficacy profile of Direct Oral Anticoagulants in patients with Chronic Kidney Disease: Consensus document of Società Italiana di Nefrologia (SIN), Federazione Centri per la diagnosi della trombosi e la Sorveglianza delle terapie Antitrombotiche (FCSA) and Società Italiana per lo Studio dell’Emostasi e della Trombosi (SISET) 939
Thrombotic sinusoiditis and local diffuse intrasinusoidal coagulation in the liver of subjects affected by COVID-19: The evidence from histology and scanning electron microscopy 912
Aortic vulnerability to COVID-19: Is the microvasculature of vasa vasorum a key factor? A case report and a review of the literature 898
The management of acute venous thromboembolism in clinical practice - study rationale and protocol of the European PREFER in VTE Registry 854
Scanning electron microscopy of lung disease due to COVID-19 – a case report and a review of the literature 849
Managing anticoagulation in the COVID-19 era between lockdown and reopening phases 846
null 845
Chronic intravascular coagulation in liver cirrhosis predicts a high hemorrhagic risk 835
Chronic spontaneous urticaria: a low-grade disseminated intravascular coagulation only partially reversed by Omalizumab 827
Trial of Rivaroxaban in AntiPhospholipid Syndrome (TRAPS): Two-year outcomes after the study closure 827
null 824
Sex-based difference in anticoagulated patients with mechanical prosthetic heart valves and long-term mortality risk 793
null 789
Clinical history and gastrointestinal bleeding in patients taking oral anticoagulants 783
null 772
Comparison of anticoagulation quality between acenocoumarol and warfarin in patients with mechanical prosthetic heart valves: Insights from the nationwide PLECTRUM study 747
Position paper on the safety/efficacy profile of direct oral anticoagulants in patients with chronic kidney disease. Consensus document from the SIN, FCSA and SISET 745
Bleeding risk in very old patients on vitamin K antagonist treatment: results of a prospective collaborative study on elderly patients followed by Italian Centres for Anticoagulation 692
null 679
null 644
null 633
null 617
null 616
null 579
null 573
null 547
null 491
Over-anticoagulation by vitamin K antagonists and gender differences 485
Hormones and thrombosis: the dark side of the moon 464
Contraceptives and Thrombosis: An Intertwined Revolutionary Road 456
null 440
null 436
Performance and Interpretation of Clot Waveform Analysis 433
Why Does Rivaroxaban Not Work in Severe Mitral Stenosis? 421
Warfarin or acenocoumarol: which is better in the management of oral anticoagulants? 413
Totale 130.235
Salva come PNG Salva come JPEG
Categoria #
all - tutte 186.496
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 186.496
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20228.189 0 650 357 537 721 713 592 531 736 1.001 1.211 1.140
2022/202313.379 1.232 1.857 1.848 1.245 1.120 1.335 652 807 810 790 1.035 648
2023/202413.823 467 803 537 943 1.426 2.090 2.356 985 649 888 1.324 1.355
2024/202530.800 6.688 8.193 5.287 2.871 2.602 1.759 2.007 130 330 426 212 295
2025/20268.219 490 285 1.006 703 625 496 1.325 520 684 1.162 652 271
2026/2027656 269 387 0 0 0 0 0 0 0 0 0 0
Totale 137.696